Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

By News Health
26 minutes Ago

(MedPage Today) — The investigational orexin receptor 2 (OX2R) agonist oveporexton improved cognitive symptoms of narcolepsy type 1 (NT1) in secondary analysis of a phase II trial.
The oral agent improved attention, memory, and executive function…

Source link : https://www.medpagetoday.com/neurology/sleepdisorders/118910

Author :

Publish date : 2025-12-09 16:57:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

New BTK Inhibitor Makes Case for Earlier Use in CLL

Novel ITP Drug Helps Patients Ditch Daily Meds

FDA Probes RSV Drug Safety; Why Some Cancers Shouldn't Be Treated; New Mpox Strain

GLP-1s and Cancer: Meta-analysis Shows Little or No Link

Reducing Hospital Readmissions From Nursing Facilities

The audacious quest to light up the sky with artificial auroras